Monday, November 16, 2020

Here's What You Missed from HHS: November 15, 2020

 

 

 

 

 

 

 

Latest U.S. Department of Health & Human Services News Releases

 

 

 

 

HHS OCR Provides Technical Assistance to Ensure New Jersey Department of Children and Families Protect Parents with Disabilities from Discrimination

November 13, 2020

 

Today, the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services announces that it has provided technical assistance to the New Jersey Department of Children and Families (DCF) to ensure that parents with disabilities are protected from discrimination in DCF’s Division of Child Protection and Permanency (DCPP) programs. Read full news release

 

 

 

 

 

 

 

Trump Administration Partners with Chain and Independent Community Pharmacies to Increase Access to Future COVID-19 Vaccines

November 12, 2020

 

To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains. Read full news release

 

 

 

5 Things About COVID-19 & The USPHS Commissioned Corps

 

 

In this new video, Surgeon General Jerome Adams shares five things you should know about the US Public Health Service (USPHS) Commissioned Corps and their work to respond to the ongoing COVID-19 pandemic.

Visit the HHS YouTube Channel

 

 

 

 

OCR Settles Eleventh Investigation in HIPAA Right of Access Initiative

November 12, 2020

 

The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) announces its eleventh settlement of an enforcement action in its HIPAA Right of Access Initiative. Read full news release

 

 

 

HHS allocates Lilly therapeutic to treat patients with mild to moderate COVID-19

November 10, 2020

 

The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Eli Lilly and Company’s investigational monoclonal antibody therapeutic, bamlanivimab, which received emergency use authorization from the U.S. Food and Drug Administration November 9 for the treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19. Read full news release

 

 

 

 

 

 

 

Visit CDC.gov for more public health updates on the COVID-19 pandemic and information on how to protect yourself and your loved ones.

HHS and our federal partners are working together to execute a whole-of-America response to COVID-19.

Learn More »

 

 

 

 

 

U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, DC 20201
Toll Free Call Center: 1-877-696-6775
Website: HHS.gov

 

 

 

 

 

No comments:

Post a Comment